Endoglin expression on human microvascular endothelial cells association with betaglycan and formation of higher order complexes with TGF-β signalling receptors

European Journal of Biochemistry

Volumn 267, Issue 17, 2000, Pages 5550-5560

  Wong, S H ^a   Hamel, L ^a,b   Chevalier, S ^a,b   Philip, A ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Betaglycan; Endoglin; Endothelial cells; Receptor heteromerization; TGF receptors

Indexed keywords

BETAGLYCAN; ENDOGLIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM;

AFFINITY LABELS; ANTIGENS, CD; BLOTTING, WESTERN; CELL LINE; ENDOTHELIUM, VASCULAR; HUMANS; IODINE RADIOISOTOPES; MOLECULAR WEIGHT; PRECIPITIN TESTS; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEOGLYCANS; RECEPTORS, CELL SURFACE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0033851028     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2000.01621.x     Document Type: Article

References (59)

1. The transforming growth factor βs
2. Molecular and cell biology of TGF-β
3. Transforming growth factor-β3 is required for secondary palate fusion
4. Transforming growth factor-β1 deficient mice: Identification of isoform specific activities in vivo
5. TGF-β2 knock out mice have multiple developmental defects that are nonoverlapping with other TGF-β knockout phenotypes
6. Cloning of TGF-β type I receptor that forms a heterodimeric complex with the type II TGF-β receptor
7. Expression cloning of the TGF-β type II receptor, a function transmembrane serine/threonine kinase
8. TGF-β signals through a heteromeric protein kinase receptor complex
9. Mechanism of activation of the TGF-β receptor
10. GS domain mutations that constitutively activate TβR-I, the downstream signaling component in the TGF-β receptor complex
11. Phosphorylation of Ser165 in TGF-β type I receptor modulates TGF-β1-induced cellular responses
12. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system
13. Expression cloning and characterization of the TGF-β type III receptor
14. Betaglycan presents ligand to the TGF-β signalling receptor
15. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line
16. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-β
17. Endoglin is a component of the transforming growth factor (TGF)-β receptor complex of human pre-B leukemic cells
18. Endoglin modulates cellular responses to TGF-β1
19. Role of endoglin in cellular responses to transforming growth factor-β. A comparative study with betaglycan
20. Endoglin is an accessory protein that interacts with the signalling receptor complex of multiple members of the transforming growth factor-β superfamily
21. Endoglin, a TGF-β binding protein of endothelial cells is the gene for hereditary haemorrhagic telangiectasia type 1
22. Hereditary hemorrhagic telangiectasia
23. CD105 and anglogenesis
24. Molecular defects in rare bleeding disorders: Hereditary haemorrhagic telangiectasia
25. Pulmonary arteriovenous malformations
26. Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative
27. Defective angiogenesis in mice lacking endoglin
28. Transforming growth factor β: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro
29. Basic fibroblast growth factor and transforming growth factor-β1: Synergestic mediators of angiogenesis in vitro
30. Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis
31. Binding of transforming growth factor-β to cell surface proteins varies with cell type
32. Transforming growth factor-β1 specific binding proteins on human vascular endothelial cells
33. Transforming growth factor-β receptor expression on endothelial cells: Heterogeneity of type III receptor expression
34. Modulation of transforming growth factor β receptor levels on microvascular endothelial cells during in vitro angiogenesis
35. Heterogeniety of the endothelial cell and its role in organ preference of tumour metastasis
36. VCAM-1, ELAM-1, and ICAM-1 independent adhesion of melanoma cells to cultured human dermal microvascular endothelial cells
37. The biphasic effects of transforming growth factor β in angiogenesis
38. Specific binding of endocrine transforming growth factor-β1 to vascular endothelium
39. HMEC-1: Establishment of an immortalized human microvascular endothelial cell
40. Human dermal microvascular endothelial cells produce matrix metalloproteinases
41. Hemostatic properties of the SV-40 transfected human microvascular endothelial cell line (HMEC-1), a representative in vitro model for microvascular endothelium
42. Transforming growth factor-β receptor expression on human skin fibroblasts: Dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-β binding proteins
43. Induction and autocrine receptor binding of TGF-β2 during terminal differentiation of primary mouse keratinocytes
44. Interaction of transforming growth factor-β with alpha-2-macroglobulin: Role in transforming growth factor beta clearance
45. Transforming growth factor-β receptors on human endometrial cells: Identification of the type I, II and III receptors, and glycosylphosphatidylinositol anchored TGF-β binding proteins
46. The TGF-β receptors types I, II and III, form hetero-oligomeric complexes in the presence of ligand
47. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells
48. Identification of disulfide linked transforming growth factor-β1-specific binding proteins in rat glomeruli
49. A transforming growth factor-β type I receptor that signals to activate gene expression
50. Type I receptor serine-threonine kinase preferentially expressed in pulmonary blood vessels
51. Isoform-specific transforming growth factor-β binding proteins with membrane attachments sensitive to phosphatidylinositol-specific phospholipase C
52. Transforming growth factor-β receptor binding and function are cecreased in psoriatic dermal endothelium
53. CD105 (endoglin)
54. Elevated expression of endoglin, a component of the TGF-β-receptor complex, correlates with proliferation of tumor endothelial cells
55. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation
56. Signaling by chimeric erythropoietin-TGF-β receptors: Homodimerization of the cytoplasmic domain of the type I TGF-β receptor and heterodimerization with the type II receptor are both required for intracellular signal transduction
57. Transforming growth factor -β induces formation of a dithiothreitol-resistant type I/type II receptor complex in live cells
58. Reconstitution of a pentameric complex of dimeric transforming growth factor beta ligand and a type I, II III receptor in baculoviral-infected insect cells
59. TGF-β signal transduction